Cordlife Group Limited (CLIFF)

OTCMKTS · Delayed Price · Currency is USD

0.1505

+0.0481 (46.97%)

At close: Jun 9, 2026

Market Cap	22.61M -48.5%
Revenue (ttm)	28.56M -1.8%
Net Income	-8.26M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	356
Open	0.1505
Previous Close	0.1024
Day's Range	0.1505 - 0.1505
52-Week Range	0.0689 - 0.1721
Beta	0.65
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Cordlife Group

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2001

Employees 538

Stock Exchange OTCMKTS

Ticker Symbol CLIFF

Financial Performance

In 2025, Cordlife Group's revenue was 38.85 million, an increase of 40.53% compared to the previous year's 27.65 million. Losses were -12.64 million, -33.06% less than in 2024.

Financial numbers in SGD Financial Statements